BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10449609)

  • 21. Trends in cervical cancer and carcinoma in situ in Great Britain.
    Cook GA; Draper GJ
    Br J Cancer; 1984 Sep; 50(3):367-75. PubMed ID: 6466546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 23. Cervical cancer. Mass screening, incidence and mortality in Finland.
    Timonen S; Pyörälä T
    Acta Obstet Gynecol Scand Suppl; 1977; 67():13-9. PubMed ID: 269640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
    Salo H; Nieminen P; Kilpi T; Auranen K; Leino T; Vänskä S; Tiihonen P; Lehtinen M; Anttila A
    Int J Cancer; 2014 Jul; 135(1):204-13. PubMed ID: 24347441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer in Croatia: state of the art and possibilities for prevention.
    Znaor A; Strnad M
    Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.
    Lăără E; Day NE; Hakama M
    Lancet; 1987 May; 1(8544):1247-9. PubMed ID: 2884378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the cervical cancer screening programme in Mexico: a population-based case-control study.
    Hernández-Avila M; Lazcano-Ponce EC; de Ruíz PA; Romieu I
    Int J Epidemiol; 1998 Jun; 27(3):370-6. PubMed ID: 9698122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 29. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B; Grinsted P
    Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological evidence for two components of cervical cancer.
    Hakama M; Penttinen J
    Br J Obstet Gynaecol; 1981 Mar; 88(3):209-14. PubMed ID: 7470410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of invasive cervical cancer in the Swiss canton of Vaud, and a note on screening.
    Levi F; La Vecchia C; Te VC; Gutzwiller F
    J Epidemiol Community Health; 1989 Jun; 43(2):121-4. PubMed ID: 2592900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a mass screening program on the risk of cervical cancer.
    Louhivuori K
    Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cervical cancer epidemic that screening has prevented in the UK.
    Peto J; Gilham C; Fletcher O; Matthews FE
    Lancet; 2004 Jul 17-23; 364(9430):249-56. PubMed ID: 15262102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer screening in Germany.
    Schenck U; von Karsa L
    Eur J Cancer; 2000 Nov; 36(17):2221-6. PubMed ID: 11072208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors.
    Sigurdsson K; Sigvaldason H
    Acta Obstet Gynecol Scand; 2006; 85(3):343-9. PubMed ID: 16553184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?
    Nowakowski A; Wojciechowska U; Wieszczy P; Cybulski M; Kamiński MF; Didkowska J
    Eur J Epidemiol; 2017 Jun; 32(6):529-532. PubMed ID: 28780640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
    Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
    Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991.
    Sigurdsson K
    Int J Cancer; 1993 Jun; 54(4):563-70. PubMed ID: 8514448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.